Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente study suggests the increased incidence of chilblains — or, COVID toes — seen during pandemic was related to behavior changes, not the coronavirus.
Research presented at the American Society for Clinical Oncology annual meeting amplified the ways the Division of Research and The Permanente Medical Group advance cancer care.
Kaiser Permanente study findings highlight the need for patients with primary nephrotic syndrome to be identified as early as possible to prevent complications.
Using data from Kaiser Permanente and United Kingdom biobanks, researchers have identified new locations on the human genome that could relate to the risk of age-related cataract.
About 75 children are scheduled to receive their first vaccination against COVID-19 as part of the Pfizer/BioNTech vaccine clinical trial through Kaiser Permanente Northern California.
Mothers with psychiatric conditions such as depression and anxiety were more likely to have a child with autism than mothers without such conditions, new research led by Kaiser Permanente investigators finds. But the analysis found no association between use of common antidepressants by pregnant women and likelihood of autism in their children.
New Kaiser Permanente study finds continuous glucose monitors are associated with improved blood sugar control and fewer visits to the emergency room for hypoglycemia in type 2 diabetes patients treated with insulin.
Kaiser Permanente study finds declines in heart attack hospitalizations and emergency care for possible strokes reported during onset of the COVID-19 pandemic not seen in subsequent surges.
Teens diagnosed with attention deficit hyperactivity disorder (ADHD) often don’t take their medication regularly, and new Kaiser Permanente research finds the problem gets worse when they hit adulthood. The study also related non-adherence to ADHD medication with some negative health and social outcomes.
Kaiser Permanente research scientist uses her expertise in epidemiology and nutrition to improve outcomes for cancer patients and enhance their survivorship.